Clinical Trial Update: Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dynamic ctDNA-guided adjuvant therapy for stage III and IV gastric or gastroesophageal junction adenocarcinoma; currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Fudan University | Conditions: ctDNA, Gastric Cancer | Phase 2 | Status: NOT_YET_RECRUITING